A Breath of Fresh Air: Emerging Therapeutic and Diagnostic Tools for Supporting Best Practices in Non-Small-Cell Lung Cancer

Slide Lecture with Audio

Sponsored by North American Center for Continuing Medical Education, LLC

Presenters/Q&A Cohosts

George R. Blumenschein, Jr, MD
Associate Professor of Medicine
Thoracic/Head and Neck Medical Oncology
The University of Texas
M. D. Anderson Cancer Center
Houston, Texas

William J. Cardarelli, PharmD
Director of Pharmacy
Atrius Health
Harvard Vanguard Medical Associates
Watertown, Massachusetts

Learning Objectives

After completing this activity, participants should be able to:

• Describe the clinical and economic impact of treatment failure in patients with non-small-cell lung cancer (NSCLC)
• Outline the emerging role of gene expression assays in characterizing NSCLC and determining treatment
• Apply clinical data on current and emerging targeted therapy options that may be appropriate for patients with NSCLC
• Put into practice knowledge and confidence for the use of gene expression and targeted therapy to support best practices in patients with NSCLC

Target Audience

This activity is designed for managed markets physicians and pharmacists.

Activity Overview

This on-demand slide lecture with audio is available with html slides and the presentation transcript.

To be eligible for documentation of credit, participants must participate in the full activity, complete the 10-question online post test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

There is no fee associated with this activity.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this activity.

Release Date: July 30, 2010

Expiration Date: July 30, 2011

Estimated time to complete: 1 hour

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape, or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

CME Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

CPE Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education (UAN 276-000-10-024-L01-P).

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact John Savage, Director, Medical Education, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535, or by e-mail at jsavage@naccme.com. The Director of Medical Education will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Vice President, Medical Education, NACCME, may be made for a second level of review.

Independent Clinical Reviewer: Ying Li, MD, PhD, Assistant Professor, Department of Radiation Oncology, University of Texas Health Science Center at San Antonio, San Antonio, Texas

Planning Committee

The planning committee comprises George R. Blumenschein, Jr, MD, William J. Cardarelli, PharmD, Ying Li, MD, PhD; Kristin Ciszeski, Mary Johnson, Mike Kearney, Randy Robbin, and John Savage, NACCME.

Financial Disclosure and Conflicts of Interest  

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Blumenschein, Dr. Cardarelli, and Dr. Li disclosed no relevant financial relationships with any commercial interests.

Ms. Ciszeski, Ms. Johnson, Mr. Kearney, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

Off-label/unapproved uses of drugs and/or devices will be disclosed in the activity materials.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2010 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc